Kevin R. Lind
2021 - Longboard Pharmaceuticals
In 2021, Kevin R. Lind earned a total compensation of $875.1K as President and Chief Executive Officer at Longboard Pharmaceuticals, a 62% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $316,726 |
|---|---|
| Salary | $546,616 |
| Other | $11,792 |
| Total | $875,134 |
Lind received $546.6K in salary, accounting for 62% of the total pay in 2021.
Lind also received $316.7K in non-equity incentive plan and $11.8K in other compensation.
Rankings
In 2021, Kevin R. Lind's compensation ranked 9,206th out of 12,415 executives tracked by ExecPay. In other words, Lind earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,206 out of 12,415 | 26th |
Division Manufacturing | 4,086 out of 5,508 | 26th |
Major group Chemicals And Allied Products | 1,802 out of 2,378 | 24th |
Industry group Drugs | 1,602 out of 2,099 | 24th |
Industry Pharmaceutical Preparations | 1,189 out of 1,549 | 23rd |
Source: SEC filing on April 13, 2022.
Lind's colleagues
We found two more compensation records of executives who worked with Kevin R. Lind at Longboard Pharmaceuticals in 2021.